Berry Global expands manufacturing capacity to provide localised support
Berry Global Group has announcement plans to establish a second manufacturing facility and global healthcare centre of excellence in Bangalore, India.
Planned for development near the company's existing Bangalore operation, the new facility will enable the company to extend its R&D expertise and scale up production in several key healthcare sectors: ophthalmic, nasal pumps, inhalation, and injectable administrations. The increased capacity will also enhance supply in India and throughout South Asia, addressing some of the fastest growing healthcare market geographies.
“Investing in our global healthcare business in Bangalore is a significant step in supporting our pharmaceutical, over-the-counter, and medical device customers aligned to forecasted market needs,” remarked Tom Salmon, Berry Global's Chairman and CEO. "During the pandemic, we've learned that strategically placed facilities across the world provide efficient localised support for customers of any size. We believe this investment significantly benefits the India and South Asia patient populations."
Healthcare Innovation and Development
Among its development work, Berry will continue to focus on inhalation devices, including models with digital capabilities and the next generation of injectable devices. Another central area of activity will be introducing innovations in nasal and ophthalmic spray pumps and healthcare packaging for various products.
In addition to manufacturing equipment, the new facility will also house an R&D Center of Excellence. In addition to ensuring the dosing and administering of medicines are both easy and comfortable for the user, another critical design criterion will be to support customers' sustainability goals, with the existing Bangalore facility already International Sustainability and Carbon Certificate (ISCC) Plus accredited. This allows Berry to sell ISCC-certified packaging and plastic components that contribute to a circular economy approach based on advanced recycling and mass balance. The mass balance approach makes it possible to track the amount and sustainability characteristics of circular and/or biobased content in the value chain and attribute it based on verifiable bookkeeping, according to the ISCC organization.
Construction of the new facility is expected to begin later this year, with the site validated and ready for production by the summer of 2023.